These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
347 related articles for article (PubMed ID: 29395335)
1. The atypical chemokine receptor 2 limits renal inflammation and fibrosis in murine progressive immune complex glomerulonephritis. Bideak A; Blaut A; Hoppe JM; Müller MB; Federico G; Eltrich N; Gröne HJ; Locati M; Vielhauer V Kidney Int; 2018 Apr; 93(4):826-841. PubMed ID: 29395335 [TBL] [Abstract][Full Text] [Related]
2. The Atypical Chemokine Receptor 2 Limits Progressive Fibrosis after Acute Ischemic Kidney Injury. Lux M; Blaut A; Eltrich N; Bideak A; Müller MB; Hoppe JM; Gröne HJ; Locati M; Vielhauer V Am J Pathol; 2019 Feb; 189(2):231-247. PubMed ID: 30448408 [TBL] [Abstract][Full Text] [Related]
3. The NLRP3/ASC inflammasome promotes T-cell-dependent immune complex glomerulonephritis by canonical and noncanonical mechanisms. Andersen K; Eltrich N; Lichtnekert J; Anders HJ; Vielhauer V Kidney Int; 2014 Nov; 86(5):965-78. PubMed ID: 24805106 [TBL] [Abstract][Full Text] [Related]
4. The atypical chemokine receptor 2 reduces T cell expansion and tertiary lymphoid tissue but does not limit autoimmune organ injury in lupus-prone B6lpr mice. Xia W; Eltrich N; Vielhauer V Front Immunol; 2024; 15():1377913. PubMed ID: 38799420 [TBL] [Abstract][Full Text] [Related]
5. Renal Protection by Genetic Deletion of the Atypical Chemokine Receptor ACKR2 in Diabetic OVE Mice. Zheng S; Coventry S; Cai L; Powell DW; Jala VR; Haribabu B; Epstein PN J Diabetes Res; 2016; 2016():5362506. PubMed ID: 26798651 [TBL] [Abstract][Full Text] [Related]
7. Susceptibility to T cell-mediated injury in immune complex disease is linked to local activation of renin-angiotensin system: the role of NF-AT pathway. Suzuki Y; Gómez-Guerrero C; Shirato I; López-Franco O; Hernández-Vargas P; Sanjuán G; Ruiz-Ortega M; Sugaya T; Okumura K; Tomino Y; Ra C; Egido J J Immunol; 2002 Oct; 169(8):4136-46. PubMed ID: 12370342 [TBL] [Abstract][Full Text] [Related]
9. Compartment-specific expression and function of the chemokine IP-10/CXCL10 in a model of renal endothelial microvascular injury. Panzer U; Steinmetz OM; Reinking RR; Meyer TN; Fehr S; Schneider A; Zahner G; Wolf G; Helmchen U; Schaerli P; Stahl RA; Thaiss F J Am Soc Nephrol; 2006 Feb; 17(2):454-64. PubMed ID: 16382019 [TBL] [Abstract][Full Text] [Related]
10. Spatiotemporal expression of chemokines and chemokine receptors in experimental anti-myeloperoxidase antibody-mediated glomerulonephritis. van der Veen BS; Petersen AH; Belperio JA; Satchell SC; Mathieson PW; Molema G; Heeringa P Clin Exp Immunol; 2009 Oct; 158(1):143-53. PubMed ID: 19737241 [TBL] [Abstract][Full Text] [Related]
11. Expression of the chemokine monocyte chemoattractant protein-1 and its receptor chemokine receptor 2 in human crescentic glomerulonephritis. Segerer S; Cui Y; Hudkins KL; Goodpaster T; Eitner F; Mack M; Schlöndorff D; Alpers CE J Am Soc Nephrol; 2000 Dec; 11(12):2231-2242. PubMed ID: 11095646 [TBL] [Abstract][Full Text] [Related]
12. Programmed death 1 and its ligands do not limit experimental foreign antigen-induced immune complex glomerulonephritis. Ooi JD; Li M; Kourkoutzelos K; Yagita H; Azuma M; Holdsworth SR; Kitching AR Nephrology (Carlton); 2015 Dec; 20(12):892-8. PubMed ID: 26043977 [TBL] [Abstract][Full Text] [Related]
13. CXCR3 is involved in tubulointerstitial injury in human glomerulonephritis. Segerer S; Banas B; Wörnle M; Schmid H; Cohen CD; Kretzler M; Mack M; Kiss E; Nelson PJ; Schlöndorff D; Gröne HJ Am J Pathol; 2004 Feb; 164(2):635-49. PubMed ID: 14742268 [TBL] [Abstract][Full Text] [Related]
14. C5a is important in the tubulointerstitial component of experimental immune complex glomerulonephritis. Welch TR; Frenzke M; Witte D; Davis AE Clin Exp Immunol; 2002 Oct; 130(1):43-8. PubMed ID: 12296852 [TBL] [Abstract][Full Text] [Related]
15. Obstructive nephropathy in the mouse: progressive fibrosis correlates with tubulointerstitial chemokine expression and accumulation of CC chemokine receptor 2- and 5-positive leukocytes. Vielhauer V; Anders HJ; Mack M; Cihak J; Strutz F; Stangassinger M; Luckow B; Gröne HJ; Schlöndorff D J Am Soc Nephrol; 2001 Jun; 12(6):1173-1187. PubMed ID: 11373340 [TBL] [Abstract][Full Text] [Related]